SPECIFIC FEATURES OF THE USE OF IMMUNOCORRECTORS IN THE ELDERLY

Abstract

The article examines the specific features of using immunocorrective therapies in elderly patients, focusing on the clinical, pharmacological, and physiological aspects that determine treatment safety and effectiveness. Age-associated immune decline, multimorbidity, polypharmacy, and altered pharmacokinetics significantly influence the response to immunomodulators. The annotation highlights current therapeutic approaches, the rationale for individualized regimens, and evidence-based recommendations aimed at optimizing immunocorrection in geriatric practice.